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Immunoglobulin G from bovine milk 
primes intestinal epithelial cells for increased 
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Abstract 
A bovine colostrum fraction (BCF) was recently shown to enhance the adherence of several commensal organisms 
to intestinal epithelial cells through modulating the epithelial cell surface. In this study, the main components of the 
BCF were examined to investigate the active component/s responsible for driving the changes in the intestinal cells. 
The adherence of various bifidobacteria to HT-29 cells was increased when the intestinal cells were pre-incubated 
with immunoglobulin G (IgG). Modulation of the intestinal cells by IgG was concentration dependent with 16 mg/
mL IgG resulting in a 43-fold increase in the adhesion of Bifidobacterium longum NCIMB 8809 to HT-29 cells. Periodate 
treatment of colostral IgG prior to performing the colonization studies resulted in a reduction in the adhesion of the 
strain to the intestinal cells demonstrating that the glycans of IgG may be important in modulating the intestinal cells 
for enhanced commensal adhesion. IgG isolated from mature milk also resulted in significant increases in adhesion of 
the Bifidobacterium strains tested albeit at reduced levels (3.9-fold). The impact of IgG on the HT-29 cells was also visu-
alised via scanning electron microscopy. This study builds a strong case for the inclusion of IgG ingredients sourced 
from cow’s milk in functional foods aimed at increasing numbers of health promoting bacteria in the human gut.
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Key points
• IgG from milk modulates intestinal cells increasing 
the adherence bifidobacteria.
• The bioactivity of IgG is concentration dependent.
• The glycans of IgG are involved in modulating the 
intestinal cells.
• IgG sourced from cow’s milk has potential as a func-
tional food ingredient.
Introduction
Bifidobacteria are among the first bacteria to colonize the 
human gastrointestinal tract and are believed to confer 
beneficial health benefits on their host (O’Callaghan and 
van Sinderen 2016; Plaza-Diaz et al. 2018). These bacte-
ria exhibit health-promoting or probiotic effects such as 
modulation of the immune system (O’Hara and Shana-
han  2007), protection of the host against pathogens by 
competitive exclusion (Bernet et  al.  1994; Hooper et  al. 
1999) and provision of nutrients through the degrada-
tion of non-digestible dietary carbohydrates (Roberfroid 
et  al.  1995; Leahy et  al. 2005). Bifidobacteria not only 
need to survive GI transit, they also need to colonize the 
GI tract. An effective probiotic must reside at the pre-
ferred target sites in the GI tract long enough and at ade-
quate concentrations to confer probiotic effects. There 
are currently no commercial products available that aid 
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or increase the attachment of health-promoting bacteria 
to the gut mucosal surface despite the growing market 
for probiotics.
The ingestion of colostrum and milk may be expected 
to have the greatest influence on microbial colonization 
in the early stages of life. Milk not only helps to inoculate 
the infant with a milk associated microbiota (Jost et  al. 
2013), but colostrum, the first milk, may be expected 
to have the greatest effect on the intestinal epithelium. 
The milk secreted by cows during the first few days after 
parturition is known as colostrum. It contains many 
essential nutrients and bioactive constituents, including 
immunoglobulins, growth factors, α-lactalbumin (α-LA) 
and β-lactoglobulin (β-lg), lysozyme, lactoperoxidase, 
lactoferrin (LF), nucleosides, cytokines, vitamins, pep-
tides and oligosaccharides, all of which are relevant to gut 
health (Pecka-Kielb et al. 2018). It should be noted how-
ever, that β-lg is not found in human milk (Brignon et al. 
1985). In certain parts of the world, bovine colostrum is 
used as a food supplement since many studies have indi-
cated that it may have anti-atherosclerotic, anti-cancer, 
anti-bacterial and anti-oxidant properties (Godhia and 
Patel 2013). Importantly, it can stimulate the develop-
ment and function of the gastrointestinal tract (Hadorn 
et  al. 1997; Guilloteau et  al.1997; Blum and Hammon, 
2000a, b). Studies have shown the potential of colostrum 
in restoring the composition of the intestinal microbi-
ome and in supporting the healing of damaged mucosa 
(Champagne et  al. 2014; Playford et  al. 1999; Cairang-
zhuoma et  al. 2013) and may in part explain its grow-
ing popularity as a supplement aimed at improving gut 
health. For instance, bovine colostrum has been shown 
to increase the activity of specific brush-border enzymes 
and decrease severity of necrotising enterocolitis when 
compared with feeding milk formula in preterm born 
piglets (Støy et  al. 2014). In term-born piglets, bovine 
colostrum reduced the intestinal colonisation of entero-
toxigenic Escherichia coli unlike milk replacer (Sugiharto 
et al. 2015). Poulsen et al. (2017) demonstrated that there 
was a higher abundance of LAB genera (for example, Lac-
tococcus and Leuconostoc) observed in bovine colostrum-
fed piglets when compared with milk replacer-fed piglets. 
Another recent study demonstrated its effectiveness in 
decreasing intestinal permeability in athletes during peak 
training for competition (Halasa et al. 2017). While these 
studies demonstrate bovine colostrum can modulate the 
intestinal epithelium and the gut microbiota profile, the 
exact mechanisms by which these changes occur and the 
individual milk components responsible remain largely 
unknown.
We recently demonstrated via in  vitro assays that 
bovine colostrum modifies the intestinal cell surface, and 
in turn the attachment of bifidobacteria and lactobacilli 
(Morrin et al. 2019a). In the study, human HT-29 intes-
tinal cells were exposed to a bovine colostrum fraction 
(BCF) which resulted in an up to 52-fold increase in 
bacterial attachment to the mammalian cells. The fact 
that exposure of the HT-29 cells to the BCF resulted in 
increased adherence of all bifidobacterial strains tested 
and a commercial probiotic Lactobacillus strain is of par-
ticular interest. Importantly, alteration of the HT-29 cell 
surface did not result in increased adhesion of the enteric 
pathogens tested (Morrin et  al. 2019a). Analysis of the 
transcriptome, proteome and glycome of the intestinal 
cells following treatment with BCF indicated that the 
cell surface was being modulated through changes in the 
expression levels of certain glycoproteins and through 
enzymatic addition of glycans to glycoconjugates (Mor-
rin et al. 2019a, b). In the current study, we aim to inves-
tigate the milk component/s in the BCF responsible for 
promoting the adherence of commensal bacteria to the 
human intestinal cells. Compositional analysis of the BCF 
was performed and the individual components present 
in the BCF were examined for their effect on the HT-29 
cells and in turn bifidobacterial adhesion.
Materials and methods
Materials
The oligosaccharide standards, 3′-siallyllactose (3′-SL) 
and 6′-sialyllactose (6′-SL) were purchased from Carbo-
synth Ltd (Berkshire, UK). Bovine milk derived α-LA and 
β-lg were supplied by Merck (Darmstadt, Germany).
Isolation of bovine colostrum fraction (BCF)
Bovine colostrum (Day 1) and mature milk were col-
lected from Holstein–Friesian cattle on-site at Teagasc 
Food Research Centre, Moorepark (Fermoy, Cork, Ire-
land) and underwent fat and casein removal using con-
ventional methods as described by Kobata et  al. (1969). 
In brief, defatting was performed through centrifugation 
and then caseins were precipitated under acidic condi-
tions (1  M HCl) and then removed through centrifuga-
tion. Many of the larger peptides were reduced from the 
resulting supernatant by ultrafiltration and lactose was 
reduced using a Sephadex G-25 column (Pharmacia, 
Uppsala, Sweden). The bovine colostrum fraction was 
isolated using High pH Anion Exchange Chromatogra-
phy with Pulsed Amperometric Detection as previously 
described by Morrin et al. (2019a).
SDS‑PAGE analysis of the BCF
Sample preparation and reduction for sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
analysis was performed as per manufacturer’s instruc-
tions (BioRad Laboratories Ltd., Hertfordshire, UK). The 
BCF were separated on a 4–12% pre-cast polyacrylamide 
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gel (BioRad Laboratories Ltd., Hertfordshire, UK) using 
13  µL of sample (containing 10  μg of protein). Protein 
bands were visualized on the gels using Coomassie blue 
stain (Merck) following the manufacturer’s procedure.
Compositional analysis of the BCF
The oligosaccharide content of the BCF was estimated 
using High pH Anion Exchange Chromatography with 
Pulsed Amperometric Detection (HPAEC-PAD) as 
per Morrin et  al. (2019a). Samples were separated and 
quantified for lactose using an Aminex HPX 87C Car-
bohydrate column (30,067.8  mm) (Bio-Rad, UK) fixed 
ion resin column as per Morrin et al. (2019a). Levels of 
β-lactoglobulin (β-lg) and α-lactalbumin (α-LA) were 
determined using a TSK G2000SW (300 × 7.5 mm) and a 
TSK G2000swxl column (300 × 7.8 mm, from Tosu Hass, 
Japan) linked in series and fitted to a Waters Alliance 
2695 separation module (Waters Corporation, Milford, 
Mass, USA) as per Morrin et  al. (2019a). Levels of LF, 
immunoglobulin G (IgG) and A (IgA), were determined 
using ELISA quantification kits (Bethyl Laboratories, Inc. 
Cambridge Bioscience, Cambridge, UK) as per Morrin 
et al. (2019a).
Isolation of oligosaccharides and lactose from the BCF
The BCF (4  mg/mL) was fractionated by centrifugal fil-
tration using a 3  kDa MWCO (Merck Millipore, Cork, 
Ireland). HPAEC-PAD analysis, as described above, con-
firmed the permeate contained the oligosaccharides and 
lactose while the retentate contained proteins and pep-
tides greater than 3 kDa (confirmed by HPLC, previously 
described above). The permeate was examined in the 
adhesion assay described below.
Isolation of IgG from bovine colostrum and milk
Day 1 colostrum and mature milk samples were pooled 
separately and defatted and decaseinated as described 
by Kobata et  al. (1969). Due to the relatively low lev-
els of IgG in mature milk, an ultrafiltration (UF) step 
was employed using a 50  kDa molecular weight cut-off, 
spiral-wound, polymeric membrane at 50  °C (Synder 
Membrane Technology Co., Ltd., Vacaville, USA). Con-
firmed via the quantification methods mentioned previ-
ously, this step resulted in higher transmission levels of 
IgG from the mature milk fraction, prior to its subse-
quent purification. Soluble IgG was isolated from the 
pooled skimmed bovine colostrum and mature milk 
using a 5  mL HiTrap Protein G column, Sepharose HP 
as per manufacturer’s instructions (GE Healthcare, Lit-
tle Chalfont, UK). The skimmed colostrum was diluted 
in  dH2O to give 2% (w/v) total solids and further diluted 
1:1 in binding buffer (20 mM phosphate buffer, pH 7.4) to 
give a concentration of 11 mg/mL. The skimmed mature 
milk was freeze dried and resuspended in binding buffer 
(20  mM phosphate buffer, pH 7.4) to give a concentra-
tion of 32 mg/mL. Separately, both samples were loaded 
on to the column which was equilibrated with the bind-
ing buffer at a flow rate of 4  mL/min. The column was 
washed with 5 column volumes (25 mL) of binding buffer 
and IgG was eluted with elution buffer (100 mM glycine–
HCl, pH 2.7). The recovered IgG-containing fractions 
were immediately neutralized with 1 M Tris⁄HCl (pH 9) 
and the protein concentration was determined using the 
Quick Start Bovine γ-Globulin Standard (BioRad Labora-
tories Ltd.). Fractions with the highest concentration of 
IgG from each run were pooled. The protein profile of the 
sample at each step was analysed by reducing SDS-PAGE 
as described above to confirm the purity of pooled IgG 
sample. The purified IgG samples were then freeze-dried 
and stored at 4 °C.
Bacterial strains growth conditions
Bifidobacterium longum subsp. infantis (ATCC ® 
15697™), Bifidobacterium longum NCIMB 8809 and Bifi-
dobacterium breve NCFB 2258 were obtained from the 
American Type Culture Collection (ATCC, Middlesex, 
UK), the National Collection of Industrial and Marine 
Bacteria (Aberdeen, Scotland, UK) and the National Col-
lection of Food Bacteria at the AFRC Institute of Food 
Research (Reading, UK) respectively. The strains were 
stored in deMan Rogosa Sharpe (MRS) (Difco, Sparks, 
MD, USA) broth containing 50% glycerol at − 80 °C until 
they were re-cultured according to the supplier’s instruc-
tions. The strains were cultured at 37  °C under anaero-
bic conditions generated using an Anaerocult A system 
(Merck). To prepare mid-exponential phase cells, over-
night cultures were adjusted to an optical density of 0.3 
and the cultures were then grown for a further 2 h and 
then adjusted to an optical density  (OD600nm) of 0.45–0.5.
Epithelial cell line conditions
The human colon adenocarcinoma cell line HT-29 was 
purchased from the American Type Culture Collection 
(ATCC). HT-29 cells were routinely grown in McCoy’s 
5A modified medium (Merck). All cells were routinely 
maintained in 75 cm2 tissue culture flasks and incubated 
at 37  °C in a humidified atmosphere (5%  CO2). Cells 
were passaged when the confluency of the flasks reached 
approximately 80%. HT-29 cells were seeded into 12 well 
plates  (Corning®, NY, USA) at a concentration of 1 × 105 
cells/well and incubated at 37 °C in 5%  CO2 in a humidi-
fied atmosphere. The cells were fed every second day 
with McCoy’s media (10%, v/v, FBS (Merck)) until 100% 
confluency was reached.
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Cell culture and exposure of HT‑29 cells to individual BCF 
components
Prior to sample exposure, the cells were washed and 
placed in McCoy’s 5A modified medium supplemented 
with 2% (v/v) FBS. After 24  h, the cells were washed 
with phosphate buffered saline and treated with filter-
sterilised milk components (described below) which 
had been re-suspended in pre-heated un-supplemented 
McCoy’s 5A modified medium. Non-supplemented 
McCoy’s 5A medium was used as a non-treated control 
(NT). The cells were then washed with phosphate buff-
ered saline and the treatments (described below) were 
applied. The plates were then incubated at 37 °C for 24 h 
in a humidified atmosphere (5%  CO2) prior to bacterial 
exposure. The HT-29 cells were exposed to the following 
treatments: Oligosaccharides and lactose (permeate of 
3  kDa cut-off of BCF, total concentration of 4  mg/mL), 
α-LA (8  mg/mL), β-lg (8  mg/mL) and IgG (24  mg/mL). 
To determine if IgG concentration influenced the HT-29 
cells and in turn the adherence of commensal bacte-
ria, the adhesion assay was repeated as described above 
using IgG at the following concentrations: 2, 6, 8, 12, 16 
and 24 mg/mL. To determine if IgG isolated from mature 
milk influenced the HT-29 cell surface and subsequently 
commensal adherence, the adhesion assay was once again 
repeated using mature milk derived IgG. Mature IgG was 
tested at a concentration of 16 mg/mL corresponding to 
the optimum concentration revealed in the concentration 
dependency assay of colostral IgG. All experiments were 
performed in triplicate. Before bacterial exposure, the 
HT-29 cells were washed three times with PBS to remove 
residual milk components.
Adhesion assay
An overnight culture of either Bifidobacterium longum 
subsp. infantis ATCC ® 15697™, Bifidobacterium longum 
NCIMB 8809 or Bifidobacterium breve NCFB 2258ATCC 
15697 was adjusted to an optical density  (OD600nm) of 
between 0.45 and 0.5 by centrifugation (3920g for 10 min) 
as per Kavanaugh et  al. (2013). The bacterial cells were 
washed twice in un-supplemented McCoy’s 5A modified 
medium before re-suspension in the same media. The 
bacterial cells were then exposed to the treated intestinal 
cells for 2 h at 37 °C under anaerobic conditions using an 
Anaerocult A system (Merck). Exposure conditions were 
adjusted before the experiment to maintain maximal 
viability of bacterial and HT-29 cells. The wells were then 
washed four times with PBS to remove non-adherent 
bacteria and lysed with 500 µl/well of 0.1% Triton X100 
(Merck) for 10  min at 37  °C. The lysates were serially 
diluted and bacteria enumerated by spread-plating on 
MRS plates. The plates were incubated anaerobically at 
37 °C for 48 h and CFU were then counted. Adhesion was 
determined as the fold change difference between the 
bacteria attached to the control (non-treated, NT) HT-29 
cells and bacteria attached to the treated HT-29 cells. 
Fold adhesion = [CFU/mL of recovered adherent bacteria 
on treated HT-29 cells/CFU/mL of recovered adherent 
bacteria on control (NT) HT-29 cells]. Adhesion assays 
were performed in triplicate over 3 successive passages of 
intestinal cells.
Sodium metaperiodate treatment of colostral IgG
Sodium metaperiodate treatment of colostral IgG was 
performed as previously described by Alemka et  al. 
(2010). IgG (24  mg/mL) was incubated with 0.011  mM 
sodium metaperiodate (Merck) dissolved in PBS. The 
mixture was then incubated at room temperature for 
30  min. Excess sodium metaperiodate was removed by 
centrifugal filtration using a 3-kDa molecular weight cut-
off with 3 × 1 mL PBS, pH 7.4, washes and the retentate 
containing meta-periodate treated IgG was diluted to its 
original volume and stored at − 20 °C. The adhesion assay 
was then carried out with the metaperiodate-treated IgG 
and B. longum 8809 as described above.
Scanning electron microscopy of Bifidobacterium longum 
NCIMB 8809 adhesion to IgG‑treated HT‑29 cells
Scanning electron microscopy (SEM) was employed to 
visualise the attachment of Bifidobacterium cells to IgG 
treated HT-29 cells versus untreated HT-29 cells. For 
adhesion assays, HT-29 cells (approximately 1 × 105 cells/
mL) were seeded in 12-well tissue culture plates (Merck) 
on microscopy cover glasses in McCoy’s 5A modified 
medium (Merck) and incubated at 37 °C in a humidified 
atmosphere of 5% CO2, until reaching 90 to 100% con-
fluency. HT-29 cells were exposed to 16  mg/mL colos-
tral IgG as described previously. Non-supplemented 
McCoy’s 5A medium was used as a non-treated control 
(NT). The adhesion assay was performed as previously 
described above. After 2 h of incubation with B. longum 
8809, the cells were then observed by Scanning Electron 
Microscopy (SEM) using the method of Khokhlov et  al. 
(2012). The HT-29 monolayer was washed three times 
with 1  mL PBS and fixed with 4% (w/v) glutaraldehyde 
(Merck), in 0.1 M phosphate (PB) buffer, (pH 6.8–7.4) for 
1 h at room temperature. After washing three times with 
PBS, the HT-29 monolayer was dehydrated in a graded 
ethanol series (25%  v/v, 50%  v/v, 75%  v/v, 95%  v/v and 
100%  v/v). The cells were air dried and sputter coated 
with chromium gold (Emitech K550X, Ashford, UK). 
The microscope cover glasses were then examined with 
a Field Emission Scanning Electron Microscope at 7 kV 
(FE-SEM; Zeiss Supra Gemini, Darmstadt, Germany).
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Results
Compositional analysis of the BCF
Compositional analysis revealed that the BCF contained 
1.68 mg/mL lactose (42% of total solids TS), 0.56 mg/mL 
sialyllactose (3′SL and 6′SL, 14% TS), 8 μg/mL α-LA and 
8.1 μg/mL β-lg. Further analysis via ELISA demonstrated 
that the BCF contained 24  μg/mL IgG, 0.04  μg/mL IgA 
and trace amounts of lactoferrin (1.92 × 10−6 mg/mL). 
Most likely‚ much of the remaining TS in the BCF con-
sists of inorganic mineral matter (ash) which is present 
in bovine milk at levels up to 7–8 g/L (Luce and Horne 
2009). Indeed, the membrane filtration step would have 
concentrated levels of ash, organic acids and non-protein 
nitrogen present in the BCF. SDS-PAGE analysis of the 
BCF revealed the presence of four main protein bands 
at 13 kDa, 16 kDa, 25 kDa and 50 kDa (data not shown). 
Considering the HPLC and ELISA results in combina-
tion with the SDS-PAGE, it was concluded that the main 
components of the BCF included α-LA, β-lg, IgG, oligo-
saccharides and lactose.
Identification of active component/s in the BCF
Increases in adhesion of Bifidobacterium longum subsp. 
infantis ATCC 15697 to HT-29 cells after prior expo-
sure to the major components of BCF were investi-
gated (Table 1). The oligosaccharide and lactose fraction 
(MW ~ 300–1200  Da) present in the 3  kDa permeate 
of the BCF did not result in an increase in adhesion of 
B. longum subsp. infantis to the HT-29 cells (p < 0.05). 
Although the BCF was found to contain IgG, α-LA and 
β-lg in µg/mL quantities, we increased the concentration 
used in the assays to mg/mL (24, 8 and 8 mg/mL respec-
tively) to be more reflective of physiological concentra-
tions found in milk. As the BCF underwent membrane 
filtration, the proteins in the sample may be fragments 
of the intact proteins which may still be detected by 
the ELISAs. For this reason, it would have been impos-
sible to replicate the status of the proteins/peptides in 
the BCF for the purposes of the bioassays and therefore 
concentrations were increased 1000-fold. Each protein 
was examined individually for their ability to increase 
the adhesion of the B. infantis 15697 to the HT-29 cells 
(p < 0.05). While α-LA and β-lg at these concentrations 
had little effect on adhesion, IgG resulted in dramatic 9.2-
fold increase in the adhesion of the strain (p < 0.05).
IgG primes intestinal epithelial cells for increased 
colonization of bifidobacteria
Two further Bifidobacterium sp. were then examined for 
their adherence to HT-29 cells that had been exposed to 
24 mg/mL of IgG (Fig. 1). Bifidobacterium longum subsp. 
longum NCIMB 8809 and Bifidobacterium breve 2258 
Table 1 Adhesion of  Bifidobacterium longum subsp. 
infantis 15697 to  HT-29 cells treated with  the  various 
components present in the BCF
Fold change p value
Lactose and Oligosaccharides 0.4 3.5 × 10−10
IgG (24 mg/mL) 9.2 9.7 × 10−4
α-lactalbumin (8 mg/mL) 0.4 2.2 × 10−7
β-lactoglobulin (8 mg/mL) 1.3 7.2 × 10−3
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Fig. 1 Adhesion of (a) Bifidobacterium longum NCIMB 8809 and (b) 
Bifidobacterium longum subsp. infantis 2258 to IgG treated HT-29 cells. 
*Denotes a significant difference compared to the control, where 
p < 0.05
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displayed a 14.5-fold and a 8.6-fold increase in adhesion 
(p < 0.05) respectively suggesting that IgG or fragments 
thereof in the BCF was responsible for the adherent phe-
notype of the HT-29 cells. To examine the effect of IgG 
concentration on the HT-29 cells, the cells were exposed 
to IgG concentrations ranging from 2 to 24  mg/mL 
(Fig. 2). The highest increase (43-fold, p < 0.05) in adher-
ence of Bifidobacterium longum subsp. longum NCIMB 
8809 to the cells was observed after exposure to 16 mg/
mL IgG. The fold change in adhesion decreased after the 
16 mg/mL IgG exposure, indicating that this concentra-
tion was the optimum for bioactivity. 
The HT-29 cells were then exposed to sodium meta-
periodate-treated IgG and the adhesion assay was per-
formed with the B. longum strain. No significant increase 
in adherence was observed in cells exposed to periodate 
treated IgG (Fig. 3). Periodate oxidation of glycoproteins 
converts vicinal diols of oligosaccharide residues to 2 
aldehyde groups, making the carbohydrate structures 
biologically unrecognizable. This result suggests that 
IgG glycosylation plays a very important role in driv-
ing the HT-29 adherent phenotype. Exposure of HT-29 
cells to IgG isolated from mature bovine milk (Fig. 4) also 
resulted in a significant increase in adhesion of B. longum 
NCIMB 8809 (3.9-fold, p < 0.05) and B. longum subsp 
infantis ATCC 15697 (3.8-fold, p < 0.05). The increase in 
the adhesion of both strains was significantly lower when 
compared to colostral IgG treated HT-29 cells, suggest-
ing that changes in IgG across lactation such as variations 
in glycosylation influence the bioactivity. 
Scanning electron microscopy of cells exposed to IgG 
(Fig. 5) revealed phenotypic differences compared to the 
control (non-treated) HT-29 cells with the surface of 
the IgG treated cells appearing smoother. Examination 
of B. longum NCIMB 8809 adhesion to control and IgG 
treated HT-29 cells was also visualised by SEM (Fig. 5). 
The attachment of higher number of Bifidobacterium 
cells to IgG treated HT-29 cells was evident when com-
pared to the non-treated control.
Discussion
Little information exists regarding the direct interaction 
of colostrum with the gastrointestinal surface and the 
ensuing effect this has on the colonisation of bacteria. 
Previously, exposure of BCF to HT-29 colonic epithelial 
cells led to a significant increase in adhesion of several 
Bifidobacterium strains (Morrin et  al. 2019a). The BCF 
was found to modify the glycosylation pattern of the cell 
surface as confirmed by gene microarray, proteomic and 
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10 10
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0C
FU
/m
L **** **** ****
**** **** ****
2.5-fold 4.5-fold
9.3-fold 36-fold 43-fold 10-fold
IgG (mg/mL)
Fig. 2 Bifidobacterium longum NCIMB 8809 adherence to HT-29 cells treated with varying concentrations of purified IgG. *Denotes a significant 
difference compared to the control where p < 0.05. Fold changes over onefold are denoted
Co
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ol
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P
100
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0C
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/m
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****
6.2-fold
Fig. 3 Bifidobacterium longum NCIMB 8809 adherence to HT-29 cells 
exposed to sodium metaperiodate-treated IgG and untreated IgG. 
*Denotes a significant difference compared to the control where 
p < 0.05. Fold changes over onefold are denoted
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lectin array analysis (Morrin et al. 2019a, 2019b). In the 
current study, we aimed to explore which component/s 
of the BCF was responsible for this bioactivity. Charac-
terisation of the BCF revealed that low levels of protein 
were present. This is expected as the fraction under-
went removal of large whey proteins such as caseins and 
fat and had also been passed through a G-25 Sephadex 
column (Morrin et al. 2019a). The analysis revealed that 
α-LA, β-lg, IgG or fragments thereof, oligosaccharides 
and lactose were the major components of the BCF and 
screening of these components for their effect on HT-29 
cells and subsequent adhesion of bifidobacteria was the 
focus of this study.
The fraction of the BCF containing the oligosaccha-
rides and lactose had no significant effect on bacterial 
adhesion when tested in this study. Similarly, α-LA and 
β-lg had little effect on the numbers of bifidobacteria 
adhering to the cells. IgG is the dominant Ig in colostrum 
and bovine milk and makes up 80–90% of the total Ig in 
colostrum (Stelwagen et  al. 2009). IgG is known for its 
potent immunological properties and its ability to deter 
gastrointestinal pathogens such as bacteria, protozoa and 
viruses (Ellens et al. 1978; Rump et al. 1992; Lissner et al. 
1996; den Hartog et  al. 2014). Three Bifidobacterium 
strains, previously shown (Morrin et al. 2019a) to adhere 
in greater numbers to HT-29 cells after exposure to BCF 
(B. infantis 15697 B. longum 8809 and B. breve 2258), 
were examined with IgG-treated HT-29 cells and a sig-
nificant increase in the adhesion of all three strains was 
observed. The effect of IgG on the HT-29 cells was con-
centration dependent with 16 mg/mL being the optimal 
concentration for increasing adherence of the bacteria. 
The effect of IgG (43-fold increase) at this concentration 
was similar to that of the original BCF which resulted in a 
52-fold increase in B. longum adhesion to the cells (Mor-
rin et al. 2019a).
IgG is heavily glycosylated and the intact IgG glycopro-
tein consists of 90% protein and 10% carbohydrate (El-
Loly 2007) with N-glycosylation conserved at the Asn297 
site of the Fc region (Takimori et  al. 2011; Recio et  al. 
2009). In this study, IgG was treated with sodium meta-
periodate, which oxidises and opens saccharide rings 
between vicinal diols. Exposure of HT-29 s cells to peri-
odate-treated IgG did not result in a significant increase 
in adhesion of the B. longum 8809 strain. This indicates 
that the glycan moieties of IgG may be largely responsi-
ble for the observed increase in bifidobacterial adhesion. 
Glycosylation of IgG is also known to vary over lactation 
(Takimori et  al. 2011; Feeney et  al. 2019). Interestingly, 
exposure of the HT-29 cells to mature IgG led to a sig-
nificant increase in adhesion of Bifidobacterium, albeit 
at a much lower level when compared to the colostral 
IgG. As the observed effect of IgG in this study is poten-
tially linked to its carbohydrate portion, the glycosyla-
tion pattern of IgG over lactation may directly correlate 
to the differences observed in adhesion between the two 
variants. The fact that IgG derived from mature bovine 
retains activity is of particular interest considering the 
commercial relevance of isolating bioactive IgG from 
mature milk and whey streams.
SEM images indicated treatment of the HT-29 epi-
thelial cell surface with both IgG and the Bifidobacte-
rium strain resulted in a smoother surface and higher 
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Fig. 4 Adhesion of (a) Bifidobacterium longum NCIMB 8809 and (b) 
Bifidobacterium longum subsp. infantis 15697 to mature milk derived 
IgG (M-IgG) treated HT-29 cells. *Denotes a significant difference 
compared to the control, where p < 0.05
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adherence of the strain compared to their non-treated 
counterparts. The smoother surface may be accredited to 
the treatment of the cell surface with either IgG or Bifido-
bacterium or both. Numerous studies have demonstrated 
the beneficial effects of dietary components (Forgie et al. 
2019; Zhao et al. 2019) and probiotics (El Aidy et al. 2013; 
Kurose et al. 2019; O’Connell Motherway et al. 2019) on 
intestinal cell integrity.
The effects of processing on IgG must also be consid-
ered as the IgG described here is isolated from raw colos-
trum and milk with minimal processing. Exposure of 
IgG to heat treatments can directly influence its confor-
mation, which in turn may alter its functionality. Many 
authors have suggested that heat treatment should be 
kept to a minimum when manufacturing Ig-based func-
tional foods (Bogahawaththa et  al. 2017; Gapper et  al. 
2007; Hurley and Theil 2013). Studies have shown heat 
treatments of above 65  °C affect the structure of Ig and 
its functions (Calmettes et al. 1991; Gapper et al. 2007; Li 
et al. 2005; Dominguez et al. 1997, 2001).
Another factor to consider in utilising IgG as food 
ingredient is the effect of digestion on the protein and 
whether it needs to survive passage through the stomach 
to reach the intestine. A number of studies examining 
the digestion of orally administered IgG in both infants 
and adults have demonstrated recovery of intact IgG in 
the faecal matter to be variable ranging between 0.01 and 
50% (Ulfman et  al. 2018). The glycosylation of IgG may 
also enhance passage through the stomach undigested as 
witnessed with other milk glycoproteins (Boutrou et  al. 
2008). In the current study, a higher concentration of 
purified IgG resulted in the optimum bioactivity in terms 
of bacterial adhesion when compared to the amount of 
IgG detected in the original BCF. However, it should be 
noted that the BCF underwent a membrane filtration 
step before purification (Morrin et  al. 2019a) and such 
processing may result in IgG fragments rather than intact 
glycoprotein. IgG can be cleaved into F(ab’)2, Fab and 
Fc fragments (Marnila and Korhonen 2002). These frag-
ments have also been detected in the stool of infants and 
adults and retain bioactivity (Zeece et  al. 2008; López-
Expósito et al. 2012). The IgG present in the original BCF 
may only represent a portion of IgG or may comprise 
Fig. 5 Monolayer of (a) non-treated and (b) IgG-treated HT-29 colonic epithelial cells with Bifidobacterium longum NCIMB 8809 (10 μm, 
magnification 1000 ×). Monolayer of (c) IgG-treated and (d) non-treated HT-29 colonic epithelial cells with Bifidobacterium longum NCIMB 8809 
(2 μm, magnification 3000 ×)
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a glycopeptide which may indeed confer enhanced 
bioactivity.
There are currently no commercial products available 
that aid or increase the attachment of health-promoting 
bacteria to intestinal cells. This crucial step in probiotic 
applications has been largely overlooked. In this context, a 
new player, represented by milk-derived IgG, may present a 
means by which the maximum benefit from consumption 
of probiotics can be achieved through influencing probiotic 
colonization in the gut. Understanding the influence of IgG 
on host-microbial interactions at the molecular level, in 
terms of both host glycan structures and bacterial adhesion 
capabilities, will be paramount for future applications. Fur-
ther studies are required to elucidate the exact sugars and 
monosaccharides of IgG which are acting on the intestinal 
cells. Overall, this study highlights the potential of bovine 
IgG as a nutraceutical for conditioning the intestine to rein-
state health-promoting bacteria in subjects with reduced 
levels of these microbes as observed with various gastro-
intestinal disorders including inflammatory bowel disease, 
obesity and metabolic syndrome.
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